Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yu-er Gao"'
Publikováno v:
Frontiers in Neurorobotics, Vol 16 (2022)
This paper presents a task prioritization strategy based on a generic underwater task goal classification transformation for multitasking underwater operational tasks: attitude control, floating manipulation, collision-free motion, especially optimiz
Externí odkaz:
https://doaj.org/article/c190c795021447e594ab26a7750f984e
Publikováno v:
2022 China Automation Congress (CAC).
Autor:
Jian Su, Yu-Er Gao, Jianxing Xiang, Zhi Xie, Hong-Hong Yan, Zhen Wang, Yi-Long Wu, Xuan Lin, Yi-Hui Yao, Jin-Ji Yang, Shi-Ling Zhang, Xu-Chao Zhang, Qing Zhou, Hai-Yan Tu, Analyn Lizaso, Jiang-Tao Cheng, Shuyin Chen, Hua-Jun Chen
Publikováno v:
Lung Cancer. 150:97-106
Background This single-center retrospective cohort study sought to investigate the impact of rebiopsy analysis after osimertinib progression in improving the survival outcomes. Methods Eighty-nine patients with EGFR T790M-positive advanced NSCLC who
Publikováno v:
Journal of Power Electronics. 20:1283-1294
Under unbalanced grid conditions, the controller design of a three-phase pulse width modulation (PWM) rectifier is based on an instantaneous power model. By calculating the current references of the converter according to the instantaneous power mode
Autor:
Shi-Ling Zhang, Hong-Hong Yan, Xu-Chao Zhang, Hai-Yan Tu, Hua-Jun Chen, Yi-Long Wu, Jian Su, Qing Zhou, Yi-Hui Yao, Yu-Er Gao, Jiangtao Cheng, Zhen Wang, Jin-Ji Yang, Zhi Xie
Publikováno v:
Journal of Clinical Oncology. 38:e21563-e21563
e21563 Background: Osimertinib is standard of care for patients with advanced non–small-cell lung cancer (NSCLC) carrying acquired epidermal growth factor receptor ( EGFR) T790M mutation. However, few studies have been conducted to investigate the